Dr Oliver Coleman
Many congratulations Oliver Coleman for passing his DPhil viva! Thanks to Ali Tavassoli and Paul Brennan for being his examiners. Thesis title – “Development, Synthesis and Characterisation of Chemical Probes for PHD Fingers”
Many congratulations Oliver Coleman for passing his DPhil viva! Thanks to Ali Tavassoli and Paul Brennan for being his examiners. Thesis title – “Development, Synthesis and Characterisation of Chemical Probes for PHD Fingers”
Kawamura Group DPhil students presented their work at the RSC Chemical Biology and Bio–organic Group Postgraduate Symposium in Southampton. Great job Loane Serano, Klem Simelis, Grace Roper & Raphael Reinbold for presenting their posters, and Benoit Darlot for the oral presentation on his exciting work on anti-inflammatory peptides derived from tick saliva proteins – our collaborative work with Prof. Shoumo Bhattacharya.
Congratulations Yara Alenazi for completing her D.Phil, thesis title “Targeting the chemokine signalling pathway using tick saliva peptides”. Thank you to the examiners Prof. Antje Beling and Prof. Charles Redwood. (Joint supervision – Prof. Shoumo Bhattacharya)
Celebrating women in science in the Kawamura Group! From left to right: Chiara Maniaci, Joanna Bonnici, Grace Roper, Karen Heathcote, Akane Kawamura
Congratulations Miranda Wright (SBM-CDT D.Phil) for successfully passing her D.Phil viva! Thank you to Prof. Antonello Mai from Sapienza University and Dr Emily Flashman for being her examiner (Joint-supervision with Prof. Paul Brennan)
Many congratulations to James Eaton for successfully defending his D.Phil thesis on “Characterisation of Novel Evasins”. Thanks to Prof. Gerard Graham from University of Glasgow and Prof. Chris Schofield for being his examiner, and BHF CRE for supporting his studentship. Read James’ work on tick saliva evasins [Ref 55][Ref 67][Ref 69] (Joint-supervision Prof. Shoumo Bhattacharya)
Delighted to welcome the new cohort 2018 to the Oxford-GSK-Crick Chemical Biology CDT Programme! Busy first week with trips to GSK and the Francis Crick Institute.